Founded in 1998 by visionary clinical research thought leaders, Integrium is a full-service Clinical Proof of Concept (PoC) firm that specializes in a wide range of therapeutic areas including cardiovascular, metabolic disease and dermatology research.
We play a key role in furthering new medical advancements by helping pharmaceutical companies design and execute clinical studies, ensuring they achieve their objectives on time, on budget, and with expected quality.
With cutting-edge technology and unparalleled services
Each clinical trial is conducted with the highest levels of honesty
Our experts work collaboratively with our clients, investigators and vendors
We take pride in the execution of all project tasks from start to finish
We combine best-in-class technology with practical clinical operations
We deliver first class services by proactively anticipating challenges
Tustin, CA – Integrium, LLC Executives will attend RESI on MaRS 2017 in Toronto, Canada on April 4, 2017. Hosted each year, RESI is notorious for providing meetings for hungry fundraisers and allowing them to connect with eager life science investors. Guests will also be able to hear from investors and their firsthand experience with the investing process and the best tactics for qualifying candidates.